A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy, Safety and Tolerability of 2 Doses of Aclidinium Bromide Compared with Placebo for 12 Weeks in Patients with Moderate to Severe, Stable Chronic Obst.

  • Doherty, Dennis (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date3/19/102/29/12